Combimatrix Molecular Diagnostics
Combimatrix Molecular Diagnostics (CMDX) is engaged in the development and marketing of genetic test reagents for the in-vitro diagnostic markets. The company is a wholly owned subsidiary of CombiMatrix Corporation. Its HerScan test is the Bacterial Artificial Chromosome (BAC) Comparative Genomic Hybridization (CGH) array-based test for breast cancer. CMDX develops DNA-Based diagnostic products through its patented CustomArray technology. Its diagnostic products are utilized in the treatment of cancer. The products offering of the company are sold under the brand name of HerScan. It operates through three business units namely Diagnostic Testing Services, Clinical Trials and Manufacturing. CMDX is headquartered at California, the US.